Abstract
Recent progress in mammalian genomics raises enormous expectations for rapid advances in global understanding of the genetic program. The Human Genome Sequencing Project and parallel sequencing efforts addressing other genomes are in their final stages and will bring to the public domain an influx of tens of thousands of previously unknown genes whose cellular function will remain to be evaluated. Although DNA sequence information may assist and facilitate functional and comparative analyses of model organisms, a combination of systematic genotype- and phenotype-driven functional approaches will play a critical role in the upcoming research defining the gene function. For its physiological similarity to humans and for its genetic manipulability, the mouse emerges as a key model mammalian organism in these efforts. One powerful strategy for phenotype-driven mutagenesis studies in mice combines chromosome engineering techniques with mutagenesis. There are three key elements of this strategy. First, using the LoxP / Cre recombination system in embryonic stem (ES) cells, coat color-tagged segmental deletion s and inversions are generated on selected chromosomes, and mouse strains are derived from these cells using conventional ES cell technology. These mice can serve as very potent and extremely convenient genetic tools that narrow the search area for gene(s) of interest to a limited chromosomal segment. Second, N-ethyl-N-nitrosourea, ENU, is used to mutagenize male mice in order to generate a source of genome-wide germ-line transmissible mutations. Third, mutagenized animals are crossed with inversion or deletion carriers to produce pedigrees uncovering ENU-induced recessive phenotypes. The genomic position of induced mutations underlying recessive phenotypes is instantly mapped to the chromosomal inversion or deletion intervals. Several large-scale projects have been launched using ENU alone or in combination with engineered chromosomes. A rapidly growing set of new phenotypes has begun to emerge from these studies which will ultimately provide insights into gene function.
Current Genomics
Title: Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function
Volume: 4 Issue: 1
Author(s): Jan Klysik, Monica J. Justice and Allan Bradley
Affiliation:
Abstract: Recent progress in mammalian genomics raises enormous expectations for rapid advances in global understanding of the genetic program. The Human Genome Sequencing Project and parallel sequencing efforts addressing other genomes are in their final stages and will bring to the public domain an influx of tens of thousands of previously unknown genes whose cellular function will remain to be evaluated. Although DNA sequence information may assist and facilitate functional and comparative analyses of model organisms, a combination of systematic genotype- and phenotype-driven functional approaches will play a critical role in the upcoming research defining the gene function. For its physiological similarity to humans and for its genetic manipulability, the mouse emerges as a key model mammalian organism in these efforts. One powerful strategy for phenotype-driven mutagenesis studies in mice combines chromosome engineering techniques with mutagenesis. There are three key elements of this strategy. First, using the LoxP / Cre recombination system in embryonic stem (ES) cells, coat color-tagged segmental deletion s and inversions are generated on selected chromosomes, and mouse strains are derived from these cells using conventional ES cell technology. These mice can serve as very potent and extremely convenient genetic tools that narrow the search area for gene(s) of interest to a limited chromosomal segment. Second, N-ethyl-N-nitrosourea, ENU, is used to mutagenize male mice in order to generate a source of genome-wide germ-line transmissible mutations. Third, mutagenized animals are crossed with inversion or deletion carriers to produce pedigrees uncovering ENU-induced recessive phenotypes. The genomic position of induced mutations underlying recessive phenotypes is instantly mapped to the chromosomal inversion or deletion intervals. Several large-scale projects have been launched using ENU alone or in combination with engineered chromosomes. A rapidly growing set of new phenotypes has begun to emerge from these studies which will ultimately provide insights into gene function.
Export Options
About this article
Cite this article as:
Klysik Jan, Justice J. Monica and Bradley Allan, Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350155
DOI https://dx.doi.org/10.2174/1389202033350155 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Small Molecule Inhibitors of PKCθ as Potential Antiinflammatory Therapeutics
Current Topics in Medicinal Chemistry Tetracyclines: Drugs with Huge Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma
Current Cancer Drug Targets Natural Proteinaceous Inhibitors of Serine Proteases
Current Pharmaceutical Design Novel Strategies for Preventing Diabetes and Obesity Complications with Natural Polyphenols
Current Medicinal Chemistry PET with Non-Standard Nuclides
Current Topics in Medicinal Chemistry Curcumin Nanomedicine: A Road to Cancer Therapeutics
Current Pharmaceutical Design Structure, Function and Evolution of Clostridium botulinum C2 and C3 Toxins: Insight to Poultry and Veterinary Vaccines
Current Protein & Peptide Science Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes
Mini-Reviews in Medicinal Chemistry Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review
Current Topics in Medicinal Chemistry Microvascular Obstruction After Primary Percutaneous Coronary Intervention: Pathogenesis, Diagnosis and Prognostic Significance
Current Vascular Pharmacology A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer’s Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice
Current Alzheimer Research Effects of Imidazolic Agonism on Blood Pressure, Sympathetic Activity, Left Ventricular Hypertrophy and Insulin Resistance
Current Hypertension Reviews Essential Hypertension, Cerebral White Matter Pathology and Ischemic Stroke
Current Medicinal Chemistry The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods
Current Medicinal Chemistry Neuroprotective Effects of Tetracyclines: Molecular Targets, Animal Models and Human Disease
CNS & Neurological Disorders - Drug Targets Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Antioxidants in Health, Disease and Aging
CNS & Neurological Disorders - Drug Targets